Literature DB >> 27457639

"Prediabetes": Are There Problems With This Label? No, We Need Heightened Awareness of This Condition!

William T Cefalu1.   

Abstract

The category of "prediabetes" defined by the American Diabetes Association comprises a range of intermediate hyperglycemia based on fasting or 2-h postload glucose or on HbA1c Over the recent past, the "cut points" identifying this stage have changed, i.e., a lower fasting glucose level is used. On one hand, it can be argued that the change to a lower cut point identifies a group of individuals still at higher risk and provides heightened awareness for a condition associated with higher risk for cardiovascular disease. In addition, identification of individuals at this stage may represent a chance of earlier intervention in the disease. However, the argument against this definition of prediabetes is that it disguises the differences in the three subcategories and creates problems in interpreting observations on interventions and outcomes. In addition, it can be argued that the enormous numbers of people identified with the criteria far exceeds the capacity of health care systems to respond through individual care, particularly without evidence that interventions benefit any category other than impaired glucose tolerance. Thus, there does not appear to be consensus on the definition using the cut points identified. Controversy also remains as to whether there are glycemic metrics beyond HbA1c that can be used in addition to HbA1c to help assess risk of an individual developing diabetes complications. Given the current controversy, a Point-Counterpoint debate on this issue is provided herein. In the preceding point narrative, Dr. Yudkin provides his argument that there are significant problems with this label. In the counterpoint narrative below, Dr. Cefalu argues that the cut points are appropriate and do provide useful and important information in trying to reduce the future burden of diabetes.-William T. CefaluEditor in Chief, Diabetes Care.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27457639      PMCID: PMC4955936          DOI: 10.2337/dc16-1143

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  28 in total

Review 1.  2. Classification and Diagnosis of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-01       Impact factor: 19.112

2.  Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.

Authors:  N G Forouhi; J Luan; S Hennings; N J Wareham
Journal:  Diabet Med       Date:  2007-02       Impact factor: 4.359

3.  Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose.

Authors:  Jin-Shang Wu; Yi-Ching Yang; Thy-Sheng Lin; Ying-Hsiang Huang; Jia-Jin Chen; Feng-Hwa Lu; Chih-Hsing Wu; Chih-Jen Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-07-31       Impact factor: 5.958

4.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

5.  Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S13-S22.

Authors: 
Journal:  Diabetes Care       Date:  2016-09       Impact factor: 19.112

Review 6.  Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

Authors:  Rui Li; Shuli Qu; Ping Zhang; Sajal Chattopadhyay; Edward W Gregg; Ann Albright; David Hopkins; Nicolaas P Pronk
Journal:  Ann Intern Med       Date:  2015-09-15       Impact factor: 25.391

7.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

Review 8.  Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Authors:  Hertzel C Gerstein; Pasqualina Santaguida; Parminder Raina; Katherine M Morrison; Cynthia Balion; Dereck Hunt; Hossein Yazdi; Lynda Booker
Journal:  Diabetes Res Clin Pract       Date:  2007-06-29       Impact factor: 5.602

Review 9.  Prediabetes: a high-risk state for diabetes development.

Authors:  Adam G Tabák; Christian Herder; Wolfgang Rathmann; Eric J Brunner; Mika Kivimäki
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

10.  Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis.

Authors:  Tianyu Xu; Wangkai Liu; Xiaoyan Cai; Jian Ding; Hongfeng Tang; Yuli Huang; Yunzhao Hu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  17 in total

Review 1.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

Review 2.  Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases.

Authors:  Gerhard H Scholz; Markolf Hanefeld
Journal:  Visc Med       Date:  2016-10-07

3.  Prediabetes Deserves More Attention: A Review.

Authors:  Yakubu Lawal; Fatima Bello; Yazid Suleiman Kaoje
Journal:  Clin Diabetes       Date:  2020-10

4.  Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts.

Authors:  Erin S LeBlanc; Richard E Pratley; Bess Dawson-Hughes; Myrlene A Staten; Patricia R Sheehan; Michael R Lewis; Anne Peters; Sun H Kim; Ranee Chatterjee; Vanita R Aroda; Chhavi Chadha; Lisa M Neff; Irwin G Brodsky; Clifford Rosen; Cyrus V Desouza; John P Foreyt; Daniel S Hsia; Karen C Johnson; Philip Raskin; Sangeeta R Kashyap; Patrick O'Neil; Lawrence S Phillips; Neda Rasouli; Emilia P Liao; David C Robbins; Anastassios G Pittas
Journal:  Diabetes Care       Date:  2018-06-25       Impact factor: 19.112

5.  Diabetes Care: "Taking It to the Limit One More Time".

Authors:  William T Cefalu; Andrew J M Boulton; William V Tamborlane; Robert G Moses; Derek LeRoith; Eddie L Greene; Frank B Hu; George Bakris; Judith Wylie-Rosett; Julio Rosenstock; Steven E Kahn; Katie Weinger; Lawrence Blonde; Mary de Groot; Stephen Rich; David D'Alessio; Lyn Reynolds; Matthew C Riddle
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

6.  Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.

Authors:  William T Cefalu; John B Buse; Jaakko Tuomilehto; G Alexander Fleming; Ele Ferrannini; Hertzel C Gerstein; Peter H Bennett; Ambady Ramachandran; Itamar Raz; Julio Rosenstock; Steven E Kahn
Journal:  Diabetes Care       Date:  2017-02       Impact factor: 19.112

Review 7.  Prediabetes in Colombia: Expert Consensus.

Authors:  Patricio López-Jaramillo; Carlos Calderón; Jorge Castillo; Iván Darío Escobar; Enrique Melgarejo; Gustavo Adolfo Parra
Journal:  Colomb Med (Cali)       Date:  2017-12-30

8.  Type 2 Diabetes: When Does It Start?

Authors:  Hiroyuki Sagesaka; Yuka Sato; Yuki Someya; Yoshifumi Tamura; Masanori Shimodaira; Takahiro Miyakoshi; Kazuko Hirabayashi; Hideo Koike; Koh Yamashita; Hirotaka Watada; Toru Aizawa
Journal:  J Endocr Soc       Date:  2018-04-18

9.  Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts.

Authors:  Aaron Leong; Natalie Daya; Bianca Porneala; James J Devlin; Dov Shiffman; Michael J McPhaul; Elizabeth Selvin; James B Meigs
Journal:  Diabetes Care       Date:  2017-10-26       Impact factor: 19.112

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.